Abstract
These in vitro experiments suggest that triple drug combination therapy may result in coresistant HIV-1 virus. However, the authors emphasize that the in vivo clinical effect of simultaneous administration of three reverse transcriptase inhibitors may yet prove beneficial in the treatment of HIV-1 disease.
- Copyright © 1995 by the American Academy of Pediatrics
Individual Login
Log in
You will be redirected to aap.org to login or to create your account.
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
CONVERGENT COMBINATION THERAPY CAN SELECT VIABLE MULTIDRUG-RESISTANT HIV-1 IN VITRO
Jump to section
Related Articles
Cited By...
- No citing articles found.